§1300.75. Patient death; insurance provisions
If a patient's death is proximately caused by treatment with an individualized
investigational drug, biological product, or device, the patient's estate, heirs, or devisees are
not liable for any debt remaining after payment by insurance for charges directly incurred for
the treatment. However, this provision shall not provide an exemption to liability for charges
for nonexperimental treatments provided to the patient, including nonexperimental
treatments rendered to the patient due to complications or consequences of the experimental
treatment.
Acts 2024, No. 750, §1.